OPCs for Health & Longevity

Created on 11/08/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

OPCs are plant compounds sold as grape seed or pine bark supplements for circulation and healthy aging. Small trials suggest small, uncertain drops in blood pressure and, in type 2 diabetes, long-term blood sugar, plus modest menopausal and leg vein relief; several independent trials found none. Trial side effects were mild; added lowering alongside medication and poor product quality matter more. Research is partly maker-funded; no human aging data exist. (Full Review)

Protocol

Grape seed extract dose (blood pressure)
300 mg daily
Also 200 or 400 mg daily in trials
Pycnogenol dose
100–200 mg daily
Typically split into two or three doses
Time of day
With meals
Split doses morning and evening; no time-of-day trials exist
Time to effect
Blood pressure
By 6 weeks
Returned to baseline four weeks after stopping
HbA1c in type 2 diabetes
Within 8 weeks
Pine bark added to standard diabetes treatment
Knee osteoarthritis symptoms
Over 3 months
Pycnogenol 150 mg daily

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Bleeding disorders (hemophilia, von Willebrand disease) or surgery within two weeks
  • Peanut allergy, for grape seed products without identity testing
  • Known allergy to grapes or pine
Key Interactions
  • Calcium-channel blockers (nifedipine, amlodipine) and ACE inhibitors (enalapril, lisinopril)
  • Oral diabetes drugs (metformin; sulfonylureas, such as glimepiride)
  • Vitamin C supplements
Theoretical (inferred from mechanism)
  • Anticoagulants and antiplatelet drugs (warfarin, clopidogrel, aspirin)
  • Non-steroidal anti-inflammatory drugs (NSAIDs: ibuprofen, naproxen)
  • UGT substrates (acetaminophen, lamotrigine)
  • Antiplatelet supplements (fish oil, ginkgo, vitamin E)
  • Supplements that lower blood pressure or glucose (beetroot nitrate; berberine)
  • Surgery and dental procedures

Risk & Side Effects

  • High:
  • Medium: Blood pressure rise with vitamin C
  • Low: Mild gastrointestinal upset, dizziness and headache; Excess blood pressure or glucose lowering with medications; Reduced iron absorption
  • Speculative: Bleeding tendency; Liver injury from polymeric proanthocyanidins; Peanut allergen exposure from adulterated products

Monitoring

Marker Target Why
Blood pressure Below 120/80 mmHg Expected to change; safety check on antihypertensives
HbA1c Below 5.7% Expected to change in type 2 diabetes
Fasting glucose 70–99 mg/dL Safety check on diabetes drugs
LDL cholesterol Below 100 mg/dL Expected to change modestly
INR (on warfarin only) No established target for OPC use; track change from stable INR Safety check on anticoagulant dosing

Cadence: Baseline before the first dose; home blood pressure weekly for the first 4–6 weeks, then monthly; INR one to two weeks after starting on warfarin; fasting glucose, HbA1c and lipids at 12 weeks, then every 6–12 months

Qualitative Assessment

  • Leg heaviness, swelling and pain in venous insufficiency
  • Joint pain, stiffness and walking tolerance in osteoarthritis
  • Hot flashes and sleep quality during the menopausal transition
  • Skin dryness and texture
  • Stomach tolerance, headache and unusual bruising